Overview
Decompensated chronic heart failure (DHF) refers to a state where chronic heart failure progresses to manifest severe symptoms requiring urgent intervention, often due to impaired cardiac function leading to fluid retention and organ dysfunction 1.Diagnosis
Clinical Symptoms: Dyspnea, fatigue, edema, and signs of systemic congestion 1.
Objective Measures: Elevated natriuretic peptides (BNP/NT-proBNP), jugular venous distension, rales on auscultation, peripheral edema 1.
Imaging: Echocardiography to assess ejection fraction, ventricular function, and presence of valvular disease 1.
Electrocardiogram (ECG): To rule out arrhythmias contributing to decompensation 1.Management
Diuretics: Loop diuretics (e.g., furosemide) titrated to achieve decongestion, typically starting at 40 mg IV and adjusted based on response 1.
Vasopressors: Inotropic agents like dobutamine for hemodynamic support if hypotension is present 1.
Angiotensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Reception Blockers (ARBs): Continued use unless contraindicated, to reduce afterload and improve survival 1.
Beta-Blockers: Continued if tolerated, to improve long-term outcomes, though dose adjustments may be necessary 1.
Management of Complications: Address specific issues like arrhythmias, infection, or renal impairment 1.Special Populations
Elderly: Careful titration of diuretics to avoid dehydration and electrolyte imbalances 1.
Comorbidities: Tailor management considering coexisting conditions like renal failure or liver disease, adjusting medications accordingly 1.Key Recommendations
Initiate aggressive diuresis with loop diuretics to manage fluid overload, guided by clinical response and natriuretic peptide levels (Evidence: Moderate) 1.
Continuously monitor and adjust inotropic support as needed to maintain adequate perfusion pressure (Evidence: Moderate) 1.
Maintain guideline-directed medical therapy including ACE inhibitors/ARBs and beta-blockers unless contraindicated (Evidence: Strong) 1.
Individualize treatment for elderly patients focusing on minimizing adverse effects while managing congestion (Evidence: Expert opinion) 1.
Address and manage comorbid conditions to optimize overall patient outcomes (Evidence: Moderate) 1.References
1 Phillips PM, Phillips LJ, Much JW, Maloney C. Descemet stripping endothelial keratoplasty: six-month results of the first 100 consecutive surgeries performed solo by a surgeon using 1 technique with 100% follow-up. Cornea 2012. link